<unk>  is a novel drug developed by Cadila Pharmaceuticals to treat patients of gram-negative sepsis patients. As an immunomodulatory, it modulates the immune system of the body and hence significantly reduces mortality rate in patients with gram negative sepsis.<unk>  is a drug developed by CSIR and Cadila Pharmaceuticals under New Millennium Indian Technology Leadership Initiative (NMITLI) programme. In many cases,<unk>  has proven to provide effective care and relief to COVID patients. __TOC__
Sepsivac
Cephem
Clinatec
Nicogel
Almanac
Ciltacabtagene autoleucel
Drusen
Titermax